NCT01056731View on ClinicalTrials.gov

A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.

PHASE4CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
High Blood Pressure
Interventions
DRUG

Aliskiren and HCTZ

Aliskiren 150 mg and 300 mg Hydrochlorothiazide 12.5 mg and 25 mg

Trial Locations (7)

Unknown

Investigative Site, Bolíva

Investigative Site, Carabobo

Investigative Site, Caracas

Investigative Site, Edo Zulia

Investigative Site, Estado Monagas

Investigative Site, Falcón

Investigative Site, Maracaibo Estado Zulia

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY